RDY
Dr. Reddys Laboratories Ltd ADR
Dr. Reddys Laboratories Ltd ADR historical holders
total: 1
Causeway Capital Management Dr. Reddys Laboratories Ltd ADR transactions over time
- Total transactions:
- 40
- New positions:
- 1
- Sold out:
- 1
- Added:
- 16
- Reduced:
- 22
- Held since:
- 2013 Q4
- Held for:
- 48 quarters
- Latest activity:
- 2025 Q4
Sarah Ketterer has been an institutional investor in Dr. Reddys Laboratories Ltd ADR (RDY) since 2013 Q4. According to 2026 Q1 report, Sarah Ketterer doesn't hold any shares. The fund/company first acquired RDY in 2013 Q4, initially purchasing 256,481 shares. Since the initial investment, Causeway Capital Management has made 39 more transactions in this position.
When did Sarah Ketterer exit their RDY position?
Sarah Ketterer no longer holds Dr. Reddys Laboratories Ltd ADR (RDY). They sold off their entire position in 2025 Q4, closing out an investment that began in 2013 Q4.
When did Sarah Ketterer first invest in RDY?
Sarah Ketterer first invested in Dr. Reddys Laboratories Ltd ADR (RDY) in 2013 Q4 at the reported quarter-end price of $41.00 per share, acquiring 256,481 shares in their initial purchase.
What is Sarah Ketterer's average cost basis for RDY?
Based on historical transaction data, Sarah Ketterer's estimated cost basis for Dr. Reddys Laboratories Ltd ADR (RDY) is approximately $39.47 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $39.47
- Weighted AVG sell price:
- $36.91
RDY transactions history by Causeway Capital Management
40 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q4
|
0.00%
|
0
|
$13.98
|
|
-100% (-159,139)
|
-0.03%
|
|
2025 Q2
|
0.04%
|
159,139
|
$15.03
|
$2,391,859
|
+10.18% (+14,700)
|
+0%
|
|
2025 Q1
|
0.04%
|
144,439
|
$13.19
|
$1,905,150
|
-73.22% (-394,866)
|
-0.12%
|
|
2024 Q4
|
0.19%
|
539,305
|
$15.79
|
$8,515,626
|
+400.00% (+431,444)
|
+0.16%
|
|
2024 Q3
|
0.21%
|
107,861
|
$79.45
|
$8,569,556
|
+1.59% (+1,687)
|
+0%
|
|
2024 Q2
|
0.22%
|
106,174
|
$76.19
|
$8,089,397
|
-7.87% (-9,064)
|
-0.02%
|
|
2023 Q3
|
0.20%
|
115,238
|
$66.87
|
$7,705,965
|
-23.17% (-34,744)
|
-0.06%
|
|
2023 Q2
|
0.25%
|
149,982
|
$63.11
|
$9,465,364
|
-6.82% (-10,984)
|
-0.02%
|
|
2023 Q1
|
0.22%
|
160,966
|
$56.93
|
$9,163,794
|
+59.65% (+60,144)
|
+0.08%
|
|
2022 Q4
|
0.15%
|
100,822
|
$51.75
|
$5,217,539
|
+17.28% (+14,853)
|
+0.02%
|
|
2022 Q3
|
0.13%
|
$52.34
|
+81.93% (+38,716)
|
|||
|
2022 Q2
|
0.07%
|
$55.38
|
-32.26% (-22,505)
|
|||
|
2022 Q1
|
0.09%
|
$55.74
|
-0.75% (-529)
|
|||
|
2021 Q4
|
0.10%
|
$65.40
|
-13.59% (-11,053)
|
|||
|
2021 Q3
|
0.12%
|
$65.13
|
-50.12% (-81,719)
|
|||
|
2021 Q2
|
0.24%
|
$73.51
|
+0.76% (+1,230)
|
|||
|
2021 Q1
|
0.20%
|
$61.39
|
-16.71% (-32,477)
|
|||
|
2020 Q4
|
0.26%
|
$71.29
|
-1.70% (-3,370)
|
|||
|
2020 Q3
|
0.26%
|
$69.56
|
+34.58% (+50,796)
|
|||
|
2020 Q2
|
0.14%
|
$53.01
|
-6.65% (-10,465)
|
|||
|
2020 Q1
|
0.10%
|
$40.33
|
+234.46% (+110,300)
|
|||
|
2019 Q3
|
0.02%
|
$37.90
|
+11.98% (+5,033)
|
|||
|
2019 Q2
|
0.02%
|
$37.47
|
-2.75% (-1,188)
|
|||
|
2018 Q1
|
0.02%
|
$32.69
|
-55.02% (-52,843)
|
|||
|
2017 Q3
|
0.04%
|
$35.68
|
-49.06% (-92,500)
|
|||
|
2017 Q2
|
0.10%
|
$42.14
|
-4.72% (-9,343)
|
|||
|
2017 Q1
|
0.11%
|
$40.15
|
-9.20% (-20,057)
|
|||
|
2016 Q4
|
0.17%
|
$45.28
|
+13.78% (+26,400)
|
|||
|
2016 Q3
|
0.16%
|
$46.42
|
-34.98% (-103,057)
|
|||
|
2016 Q2
|
0.32%
|
$51.23
|
-22.51% (-85,600)
|
|||
|
2016 Q1
|
0.40%
|
$45.19
|
+1.63% (+6,100)
|
|||
|
2015 Q4
|
0.37%
|
$46.29
|
-36.23% (-212,500)
|
|||
|
2015 Q3
|
0.75%
|
$63.91
|
+7.71% (+42,000)
|
|||
|
2015 Q2
|
0.76%
|
$55.59
|
+1.78% (+9,500)
|
|||
|
2015 Q1
|
0.80%
|
$57.10
|
-11.26% (-67,912)
|
|||
|
2014 Q4
|
0.89%
|
$50.81
|
+259.36% (+435,212)
|
|||
|
2014 Q3
|
0.31%
|
$52.55
|
-13.86% (-27,000)
|
|||
|
2014 Q2
|
0.34%
|
$43.15
|
-54.19% (-230,400)
|
|||
|
2014 Q1
|
0.80%
|
$41.96
|
+65.78% (+168,719)
|
|||
|
2013 Q4
|
0.60%
|
$41.00
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.